help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, L. F.
Right arrow Articles by Senger, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, L. F.
Right arrow Articles by Senger, D. R.

American Journal of Pathology, Vol 143, 1255-1262, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas

LF Brown, B Berse, RW Jackman, K Tognazzi, EJ Manseau, HF Dvorak and DR Senger
Department of Pathology, Beth Israel Hospital, Boston, MA 02215.

Vascular permeability factor (VPF), also known as vascular endothelial growth factor, is a secreted protein implicated in tumor-associated microvascular hyperpermeability and angiogenesis. Tumor cells in 11 of 12 renal cell carcinomas expressed high levels of VPF messenger RNA (mRNA) by in situ hybridization, the only exception being a case of the relatively avascular papillary variant. Expression was further accentuated adjacent to areas of necrosis. Both tumor cells and endothelial cells in small vessels adjacent to tumor stained strongly for VPF protein by immunohistochemistry. Endothelial cells did not express detectable VPF mRNA, but did express high levels of mRNA for the VPF receptors flt-1 and KDR indicating that the endothelial cell staining likely reflects binding of VPF secreted by adjacent tumor cells. Three transitional cell carcinomas also labeled strongly for VPF mRNA. These data suggest an important role for VPF in the vascular biology of these two common human malignancies.


This article has been cited by other articles:


Home page
 FASEB J.Home page
E. L. Coutinho, L. N. de Sousa Andrade, R. Chammas, L. Morganti, N. Schor, and M. H. Bellini
Anti-tumor effect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma
FASEB J, October 1, 2007; 21(12): 3153 - 3161.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Sun, S. Stevanovic, M. Song, A. Schwantes, C. J. Kirkpatrick, D. Schadendorf, and K. Cichutek
The kinase insert domain-containing receptor is an angiogenesis-associated antigen recognized by human cytotoxic T lymphocytes
Blood, February 15, 2006; 107(4): 1476 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Bhattacharya, S. SenBanerjee, Z. Lin, S. Mir, A. Hamik, P. Wang, P. Mukherjee, D. Mukhopadhyay, and M. K. Jain
Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2
J. Biol. Chem., August 12, 2005; 280(32): 28848 - 28851.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Podar and K. C. Anderson
The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
Blood, February 15, 2005; 105(4): 1383 - 1395.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. Y. Kim and W. G. Kaelin
Role of VHL Gene Mutation in Human Cancer
J. Clin. Oncol., December 15, 2004; 22(24): 4991 - 5004.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. R. Reynolds, L. E. Reynolds, T. E. Nagel, J. C. Lively, S. D. Robinson, D. J. Hicklin, S. C. Bodary, and K. M. Hodivala-Dilke
Elevated Flk1 (Vascular Endothelial Growth Factor Receptor 2) Signaling Mediates Enhanced Angiogenesis in {beta}3-Integrin-Deficient Mice
Cancer Res., December 1, 2004; 64(23): 8643 - 8650.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Woolard, W.-Y. Wang, H. S. Bevan, Y. Qiu, L. Morbidelli, R. O. Pritchard-Jones, T.-G. Cui, M. Sugiono, E. Waine, R. Perrin, et al.
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant: Mechanism of Action, In vivo Effect On Angiogenesis and Endogenous Protein Expression
Cancer Res., November 1, 2004; 64(21): 7822 - 7835.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Ostendorf, C. van Roeyen, R. Westenfeld, A. Gawlik, M. Kitahara, E. de Heer, D. Kerjaschki, J. Floege, and M. Ketteler
Inducible Nitric Oxide Synthase-Derived Nitric Oxide Promotes Glomerular Angiogenesis via Upregulation of Vascular Endothelial Growth Factor Receptors
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2307 - 2319.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Ferrara
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Endocr. Rev., August 1, 2004; 25(4): 581 - 611.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
F. G. Blankenberg, S. Mandl, Y.-A. Cao, C. O'Connell-Rodwell, C. Contag, C. Mari, T. I. Gaynutdinov, J.-L. Vanderheyden, M. V. Backer, and J. M. Backer
Tumor Imaging Using a Standardized Radiolabeled Adapter Protein Docked to Vascular Endothelial Growth Factor
J. Nucl. Med., August 1, 2004; 45(8): 1373 - 1380.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. Brieger, M. Wierzbicka, M. Sokolov, Y. Roth, W. Szyfter, and W. J. Mann
Vessel Density, Proliferation, and Immunolocalization of Vascular Endothelial Growth Factor in Juvenile Nasopharyngeal Angiofibromas
Arch Otolaryngol Head Neck Surg, June 1, 2004; 130(6): 727 - 731.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. S. Herbst and A. B. Sandler
Non-Small Cell Lung Cancer and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?
Oncologist, June 1, 2004; 9(suppl_1): 19 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Datta, J. Li, R. Bhattacharya, L. Gasparian, E. Wang, and D. Mukhopadhyay
Protein Kinase C {zeta} Transactivates Hypoxia-Inducible Factor {alpha} by Promoting Its Association with p300 in Renal Cancer
Cancer Res., January 15, 2004; 64(2): 456 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. G. Kaelin Jr.
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2703 - 2711.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Muramaki, H. Miyake, I. Hara, and S. Kamidono
Introduction of Midkine Gene into Human Bladder Cancer Cells Enhances Their Malignant Phenotype But Increases Their Sensitivity to Antiangiogenic Therapy
Clin. Cancer Res., November 1, 2003; 9(14): 5152 - 5160.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J.-y. Liu, Y.-q. Wei, L. Yang, X. Zhao, L. Tian, J.-m. Hou, T. Niu, F. Liu, Y. Jiang, B. Hu, et al.
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
Blood, September 1, 2003; 102(5): 1815 - 1823.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Nair, D. Boczkowski, B. Moeller, M. Dewhirst, J. Vieweg, and E. Gilboa
Synergy between tumor immunotherapy and antiangiogenic therapy
Blood, August 1, 2003; 102(3): 964 - 971.
[Abstract] [Full Text] [PDF]

Home page
 INT J LOW EXTREM WOUNDSHome page
D. O. Bates and R. O. P. Jones
The Role of Vascular Endothelial Growth Factor in Wound Healing
International Journal of Lower Extremity Wounds, June 1, 2003; 2(2): 107 - 120.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
M. Y. Liu, L. Poellinger, and C. L. Walker
Up-Regulation of Hypoxia-inducible Factor 2{alpha} in Renal Cell Carcinoma Associated with Loss of Tsc-2 Tumor Suppressor Gene
Cancer Res., May 15, 2003; 63(10): 2675 - 2680.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. M. Gardner and M. E. Olah
Distinct Protein Kinase C Isoforms Mediate Regulation of Vascular Endothelial Growth Factor Expression by A2A Adenosine Receptor Activation and Phorbol Esters in Pheochromocytoma PC12 Cells
J. Biol. Chem., April 18, 2003; 278(17): 15421 - 15428.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. E. Bullard, X. Qi, and J. S. Penn
Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1722 - 1731.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Z. von Marschall, A. Scholz, T. Cramer, G. Schafer, M. Schirner, K. Oberg, B. Wiedenmann, M. Hocker, and S. Rosewicz
Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis
J Natl Cancer Inst, March 19, 2003; 95(6): 437 - 448.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Oya, A. Takayanagi, A. Horiguchi, R. Mizuno, M. Ohtsubo, K. Marumo, N. Shimizu, and M. Murai
Increased nuclear factor-{kappa}B activation is related to the tumor development of renal cell carcinoma
Carcinogenesis, March 1, 2003; 24(3): 377 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
E S Bamberger and C W Perrett
Angiogenesis in epithelian ovarian cancer
Mol. Pathol., December 1, 2002; 55(6): 348 - 359.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Minami, D. J. Donovan, J. C. Tsai, R. D. Rosenberg, and W. C. Aird
Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice
Blood, December 1, 2002; 100(12): 4019 - 4025.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. F. Dvorak
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. Stoner, B. Saville, M. Wormke, D. Dean, R. Burghardt, and S. Safe
Hypoxia Induces Proteasome-Dependent Degradation of Estrogen Receptor {alpha} in ZR-75 Breast Cancer Cells
Mol. Endocrinol., October 1, 2002; 16(10): 2231 - 2242.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Favier, P.-F. Plouin, P. Corvol, and J.-M. Gasc
Angiogenesis and Vascular Architecture in Pheochromocytomas : Distinctive Traits in Malignant Tumors
Am. J. Pathol., October 1, 2002; 161(4): 1235 - 1246.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. O. Bates, T.-G. Cui, J. M. Doughty, M. Winkler, M. Sugiono, J. D. Shields, D. Peat, D. Gillatt, and S. J. Harper
VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Is Down-Regulated in Renal Cell Carcinoma
Cancer Res., July 15, 2002; 62(14): 4123 - 4131.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Inoue, M. Chikazawa, S. Fukata, C. Yoshikawa, and T. Shuin
Frequent Administration of Angiogenesis Inhibitor TNP-470 (AGM-1470) at an Optimal Biological Dose Inhibits Tumor Growth and Metastasis of Metastatic Human Transitional Cell Carcinoma in the Urinary Bladder
Clin. Cancer Res., July 1, 2002; 8(7): 2389 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Fauconnet, I. Lascombe, E. Chabannes, G.-L. Adessi, B. Desvergne, W. Wahli, and H. Bittard
Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells
J. Biol. Chem., June 21, 2002; 277(26): 23534 - 23543.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
A. N. Witmer, J. Dai, H. A. Weich, G. F.J.M. Vrensen, and R. O. Schlingemann
Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia
J. Histochem. Cytochem., June 1, 2002; 50(6): 767 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Inoue, M. Kamada, J. W. Slaton, S. Fukata, C. Yoshikawa, P. Tamboli, C. P. N. Dinney, and T. Shuin
The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter
Clin. Cancer Res., June 1, 2002; 8(6): 1863 - 1870.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Weidner
New Paradigm for Vessel Intravasation by Tumor Cells
Am. J. Pathol., June 1, 2002; 160(6): 1937 - 1939.
[Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
W. M. HON, K. H. LEE, and H. E. KHOO
Nitric Oxide in Liver Diseases: Friend, Foe, or Just Passerby?
Ann. N.Y. Acad. Sci., May 1, 2002; 962(1): 275 - 295.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Yuan, C.-J. Yu, K.-T. Luh, S.-H. Kuo, Y.-C. Lee, and P.-C. Yang
Aberrant p53 Expression Correlates With Expression of Vascular Endothelial Growth Factor mRNA and Interleukin-8 mRNA and Neoangiogenesis in Non-Small-Cell Lung Cancer
J. Clin. Oncol., February 15, 2002; 20(4): 900 - 910.
[Abstract] [Full Text] [PDF]

Home page
 Sci SignalHome page
T. Matsumoto and L. Claesson-Welsh
VEGF Receptor Signal Transduction
Sci. Signal., December 11, 2001; 2001(112): re21 - re21.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
H. Yang and W. G. Kaelin Jr.
Molecular Pathogenesis of the Von Hippel-Lindau Hereditary Cancer Syndrome: Implications for Oxygen Sensing
Cell Growth Differ., September 1, 2001; 12(9): 447 - 455.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Hayashibara, Y. Yamada, T. Miyanishi, H. Mori, T. Joh, T. Maeda, N. Mori, T. Maita, S. Kamihira, and M. Tomonaga
Vascular Endothelial Growth Factor and Cellular Chemotaxis: A Possible Autocrine Pathway in Adult T-Cell Leukemia Cell Invasion
Clin. Cancer Res., September 1, 2001; 7(9): 2719 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. W. Slaton, T. Karashima, P. Perrotte, K. Inoue, S. J. Kim, J. Izawa, D. Kedar, D. J. McConkey, R. Millikan, P. Sweeney, et al.
Treatment with Low-Dose Interferon-{alpha} Restores the Balance between Matrix Metalloproteinase-9 and E-Cadherin Expression in Human Transitional Cell Carcinoma of the Bladder
Clin. Cancer Res., September 1, 2001; 7(9): 2840 - 2853.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. Pillebout, M. Burtin, H. T. Yuan, P. Briand, A. S. Woolf, G. Friedlander, and F. Terzi
Proliferation and Remodeling of the Peritubular Microcirculation after Nephron Reduction : Association with the Progression of Renal Lesions
Am. J. Pathol., August 1, 2001; 159(2): 547 - 560.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. Iyoda, K. Hiroshima, M. Baba, T. Fujisawa, T. Yusa, and H. Ohwada
Expression of vascular endothelial growth factor in thoracic sarcomas
Ann. Thorac. Surg., May 1, 2001; 71(5): 1635 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
J. I. Izawa and C. P.N. Dinney
The role of angiogenesis in prostate and other urologic cancers: a review
Can. Med. Assoc. J., March 1, 2001; 164(5): 662 - 670.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Datta, C. Sundberg, S. A. Karumanchi, and D. Mukhopadhyay
The 104-123 Amino Acid Sequence of the {beta}-domain of von Hippel-Lindau Gene Product Is Sufficient to Inhibit Renal Tumor Growth and Invasion
Cancer Res., March 1, 2001; 61(5): 1768 - 1775.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
C. Sundberg, J. A. Nagy, L. F. Brown, D. Feng, I. A. Eckelhoefer, E. J. Manseau, A. M. Dvorak, and H. F. Dvorak
Glomeruloid Microvascular Proliferation Follows Adenoviral Vascular Permeability Factor/Vascular Endothelial Growth Factor-164 Gene Delivery
Am. J. Pathol., March 1, 2001; 158(3): 1145 - 1160.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
Z von Marschall, T Cramer, M Hocker, G Finkenzeller, B Wiedenmann, and S Rosewicz
Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma
Gut, January 1, 2001; 48(1): 87 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. L. Feldman, L. Tamarkin, G. F. Paciotti, B. W. Simpson, W. M. Linehan, J. C. Yang, W. E. Fogler, E. M. Turner, H. R. Alexander Jr., and S. K. Libutti
Serum Endostatin Levels Are Elevated and Correlate with Serum Vascular Endothelial Growth Factor Levels in Patients with Stage IV Clear Cell Renal Cancer
Clin. Cancer Res., December 1, 2000; 6(12): 4628 - 4634.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
K. Inoue, J. W. Slaton, T. Karashima, C. Yoshikawa, T. Shuin, P. Sweeney, R. Millikan, and C. P. N. Dinney
The Prognostic Value of Angiogenesis Factor Expression for Predicting Recurrence and Metastasis of Bladder Cancer after Neoadjuvant Chemotherapy and Radical Cystectomy
Clin. Cancer Res., December 1, 2000; 6(12): 4866 - 4873.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
S. THOMAS, J. VANUYSTEL, G. GRUDEN, V. RODRÍGUEZ, D. BURT, L. GNUDI, B. HARTLEY, and G. VIBERTI
Vascular Endothelial Growth Factor Receptors in Human Mesangium in Vitro and in Glomerular Disease
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1236 - 1243.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
K. Inoue, J. W. Slaton, D. W. Davis, D. J. Hicklin, D. J. McConkey, T. Karashima, R. Radinsky, and C. P. N. Dinney
Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel
Clin. Cancer Res., July 1, 2000; 6(7): 2635 - 2643.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
N. Koshikawa, K. Takenaga, M. Tagawa, and S. Sakiyama
Therapeutic Efficacy of the Suicide Gene Driven by the Promoter of Vascular Endothelial Growth Factor Gene against Hypoxic Tumor Cells
Cancer Res., June 1, 2000; 60(11): 2936 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
R. E. Favoni and A. De Cupis
The Role of Polypeptide Growth Factors in Human Carcinomas: New Targets for a Novel Pharmacological Approach
Pharmacol. Rev., June 1, 2000; 52(2): 179 - 206.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Wood, G. Bold, E. Buchdunger, R. Cozens, S. Ferrari, J. Frei, F. Hofmann, J. Mestan, H. Mett, T. O’Reilly, et al.
PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration
Cancer Res., April 1, 2000; 60(8): 2178 - 2189.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
Y. Kondo, S. Arii, A. Mori, M. Furutani, T. Chiba, and M. Imamura
Enhancement of Angiogenesis, Tumor Growth, and Metastasis by Transfection of Vascular Endothelial Growth Factor into LoVo Human Colon Cancer Cell Line
Clin. Cancer Res., February 1, 2000; 6(2): 622 - 630.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo
Regulation of Angiogenesis via Vascular Endothelial Growth Factor Receptors
Cancer Res., January 1, 2000; 60(2): 203 - 212.
[Full Text]

Home page
 Clin. Cancer Res.Home page
B. K. Zebrowski, S. Yano, W. Liu, R. M. Shaheen, D. J. Hicklin, J. B. Putnam Jr., and L. M. Ellis
Vascular Endothelial Growth Factor Levels and Induction of Permeability in Malignant Pleural Effusions
Clin. Cancer Res., November 1, 1999; 5(11): 3364 - 3368.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. E. Tsopanoglou and M. E. Maragoudakis
On the Mechanism of Thrombin-induced Angiogenesis. POTENTIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR ACTIVITY ON ENDOTHELIAL CELLS BY UP-REGULATION OF ITS RECEPTORS
J. Biol. Chem., August 20, 1999; 274(34): 23969 - 23976.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. D. Balbay, C. A. Pettaway, H. Kuniyasu, K. Inoue, E. Ramirez, E. Li, I. J. Fidler, and C. P. N. Dinney
Highly Metastatic Human Prostate Cancer Growing within the Prostate of Athymic Mice Overexpresses Vascular Endothelial Growth Factor
Clin. Cancer Res., April 1, 1999; 5(4): 783 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. M. Ryan, D. B. Eppler, K. E. Hagler, R. H. Bruner, P. J. Thomford, R. L. Hall, G. M. Shopp, and C. A. O'Neill
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
Toxicol Pathol, January 1, 1999; 27(1): 78 - 86.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
B.-Q. Shen, D. Y. Lee, H.-P. Gerber, B. A. Keyt, N. Ferrara, and T. F. Zioncheck
Homologous Up-regulation of KDR/Flk-1 Receptor Expression by Vascular Endothelial Growth Factor in Vitro
J. Biol. Chem., November 6, 1998; 273(45): 29979 - 29985.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Krieg, H. H. Marti, and K. H. Plate
Coexpression of Erythropoietin and Vascular Endothelial Growth Factor in Nervous System Tumors Associated With von Hippel-Lindau Tumor Suppressor Gene Loss of Function
Blood, November 1, 1998; 92(9): 3388 - 3393.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Pal, K. P. Claffey, H. T. Cohen, and D. Mukhopadhyay
Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C zeta
J. Biol. Chem., October 9, 1998; 273(41): 26277 - 26280.
[Abstract] [Full Text] [PDF]